Patient Capital Management, LLC: CITIGROUP INC (C): Quarterly 13F Position History
As of Q1 2026, Patient Capital Management, LLC reported 1,413,870 shares of CITIGROUP INC (C), worth $160.3M and representing 6.0% of its 13F equity book. Quarter-over-quarter share count change: + 122,076 (+9.5%) . The position first appeared in Q1 2022 and has been disclosed across 17 13F-HR filings in Pactolio's tracked window.
- 1,413,870Shares Held (Latest Filing)
- $160.3MReported Market Value (Latest Filing)
- 6.0%Portfolio Weight (% of 13F Equity Book)
- +122,076Quarter-over-Quarter Share Change
- +$9.6MQuarter-over-Quarter Value Change
- 1,889,331Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 17 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,413,870 | +122,076 | +9.5% | $160.3M | 6.0% | $113.4 |
| Q4 2025 | 1,291,794 | 18,613 | -1.4% | $150.7M | 5.8% | $116.7 |
| Q3 2025 | 1,310,407 | 35,310 | -2.6% | $133.0M | 5.3% | $101.5 |
| Q2 2025 | 1,345,717 | 59,348 | -4.2% | $114.5M | 5.2% | $85.1 |
| Q1 2025 | 1,405,065 | 136,243 | -8.8% | $99.7M | 5.1% | $71.0 |
| Q4 2024 | 1,541,308 | 550 | -0.0% | $108.5M | 5.0% | $70.4 |
| Q3 2024 | 1,541,858 | 121,252 | -7.3% | $96.5M | 4.7% | $62.6 |
| Q2 2024 | 1,663,110 | 113,965 | -6.4% | $105.5M | 5.6% | $63.5 |
| Q1 2024 | 1,777,075 | 112,256 | -5.9% | $112.4M | 5.5% | $63.2 |
| Q4 2023 | 1,889,331 | +6,902 | +0.4% | $97.2M | 5.1% | $51.4 |
| Q3 2023 | 1,882,429 | +376,413 | +25.0% | $77.4M | 4.5% | $41.1 |
| Q2 2023 | 1,506,016 | +1,357,616 | +914.8% | $69.3M | 3.9% | $46.0 |
| Q1 2023 | 148,400 | +12,600 | +9.3% | $7.0M | 3.1% | $46.9 |
| Q4 2022 | 135,800 | 0 | — | $6.1M | 3.0% | $45.2 |
| Q3 2022 | 135,800 | 0 | — | $5.7M | 2.9% | $41.7 |
| Q2 2022 | 135,800 | +31,800 | +30.6% | $6.2M | 3.0% | $46.0 |
| Q1 2022 | 104,000 | — | — | $5.6M | 2.2% | $53.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Patient Capital Management, LLC first disclose a C position in 13F-HR filings?
Patient Capital Management, LLC first reported CITIGROUP INC (C) on its 13F-HR filing for the period ending 2022-03-31 (Q1 2022). The position has appeared on 17 reported quarters within Pactolio's tracked window.
What was Patient Capital Management, LLC's most recent quarter-over-quarter share-count change in C?
Between Q4 2025 and Q1 2026, Patient Capital Management, LLC added 122,076 shares of C (+9.5%), bringing the total reported position to 1,413,870 shares at a market value of $160.3M.
Does the implied price-per-share represent Patient Capital Management, LLC's cost basis in C?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.